Pfizer Strengthens Its Position in the Injectables Market
Debbie Tranter
Abstract
Pfizer signed a comprehensive generics deal with Strides Arcolab in January, 2010 and has now reinforced this deal to focus on new markets and additional product segments.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.